Faculty Disclosures
| Jennifer Swinton |
Mrs. Swinton has nothing to disclose. |
| Aili Golubjatnikov |
No disclosure on file
|
| Joshua Rosenblat |
Joshua Rosenblat has nothing to disclose. |
| Michael D. Geschwind, MD, PhD, FAAN |
Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc.. |
| Gia Han Le |
No disclosure on file
|
| Sangharsha Thapa, MD |
Dr. Thapa has nothing to disclose. |
| Massimo Filippi, MD, FAAN |
Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. |
| David S. Lynch, MBBS, PhD |
Dr. Lynch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuroscience. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Lynch has received research support from Ionis. |
| Penny Dacks, PhD |
Penny Dacks has received personal compensation for serving as an employee of The Association for Frontotemporal Degeneration. |
| Robin Schubert |
No disclosure on file
|
| Donald McLaren |
No disclosure on file
|
| Zyanna Stuart |
No disclosure on file
|
| Andriy Yabluchanskiy |
Andriy Yabluchanskiy has nothing to disclose. |
| Cheyenne Gutierrez |
No disclosure on file
|
| In Young Choi, PhD |
Dr. Choi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Choi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. |
| Carmen Vizzino |
No disclosure on file
|
| Sebastian Badulescu |
Sebastian Badulescu has nothing to disclose. |
| Ziji Guo |
Ziji Guo has nothing to disclose. |
| Lee Phan |
Lee Phan has nothing to disclose. |
| Lealani M. Acosta, MD, MPH, FAAN |
Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Sage, NIH, Bristol Myers Squibb/Fortrea, CND Life Sciences. |
| Andrea Mendez Colmenares, MD, PhD |
Dr. Mendez Colmenares has nothing to disclose. |
| Krishna Dahal |
No disclosure on file
|
| Carrie Milliard |
Carrie Milliard has received personal compensation for serving as an employee of FTD Disorders Registry, LCC. The institution of Carrie Milliard has received research support from NIH - PTE Mayo Clinic . |
| Kelly Goodman-O'Leary |
No disclosure on file
|
| Angela T. Kwan, MSc |
Miss Kwan has nothing to disclose. |
| Supratik Nandi |
No disclosure on file
|
| Ranuk Ramachandra |
No disclosure on file
|
| Blair Apple |
No disclosure on file
|
| Ana Luyza Oliveira Santos, MD |
Dr. Oliveira Santos has nothing to disclose. |
| Michael Terranova |
Michael Terranova has nothing to disclose. |
| Arthur Kramer |
No disclosure on file
|
| Felicia Ceban |
Felicia Ceban has nothing to disclose. |
| Judith Meadows |
No disclosure on file
|
| Elisabetta Pagani |
Elisabetta Pagani has nothing to disclose. |
| Camila Bonin Pinto |
Camila Bonin Pinto has nothing to disclose. |
| Diana Biondi |
No disclosure on file
|
| Srihari Gopal |
No disclosure on file
|
| Katherine Wong, MD |
Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Wong has stock in Biogen. |
| Guoyu Zhou |
No disclosure on file
|
| Kim Jenny |
Kim Jenny has received personal compensation for serving as an employee of The Association for Frontotemporal Degeneration. Kim Jenny has stock in Invitae. |
| Agnieszka Burzynska |
No disclosure on file
|
| Shih-Syuan Wang, MD |
Dr. Wang has nothing to disclose. |
| Sophia Fioramonti-Gorchow |
Miss Fioramonti-Gorchow has received personal compensation for serving as an employee of Regeneron Pharmaceuticals, Inc. |
| Nicolò Tedone |
Nicolò Tedone has nothing to disclose. |
| Kate Singleton |
No disclosure on file
|
| Phil Lee, PhD |
An immediate family member of Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. An immediate family member of Dr. Lee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Lee has received research support from NIH. |
| Stacy Metcalf |
No disclosure on file
|
| Kayla Teopiz |
Kayla Teopiz has received personal compensation in the range of $10,000-$49,999 for serving as a Contractor with Braxia Scientific Corp. Kayla Teopiz has received personal compensation in the range of $500-$4,999 for serving as a Contractor with Brain and Cognition Discovery Foundation. |
| Megan Casey |
No disclosure on file
|
| Theresa Driscoll |
No disclosure on file
|
| Vince Calhoun |
No disclosure on file
|
| Kaigang Li |
No disclosure on file
|
| Cameron Owens, MS |
Mr. Owens has nothing to disclose. |
| Sangam Shah |
Dr. Shah has nothing to disclose. |
| Kevin Sheng-Kai Ma |
Dr. MA has nothing to disclose. |
| Steven E. Arnold, MD |
Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP Pharma. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Boyle Shaughnessy Law. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wolf Greenfield. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Bob's Last Marathon. |
| Irina Skylar-Scott, MD |
An immediate family member of Dr. Skylar-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 3D Systems. Dr. Skylar-Scott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PeerView/Lilly. The institution of an immediate family member of Dr. Skylar-Scott has received research support from The Chan Zuckerberg Initiative. Dr. Skylar-Scott has received research support from Biogen. An immediate family member of Dr. Skylar-Scott has received intellectual property interests from a discovery or technology relating to health care. Dr. Skylar-Scott has received publishing royalties from a publication relating to health care. |
| SERGIO FAZIO |
No disclosure on file
|
| Zbigniew K. Wszolek, MD, FAAN |
Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care. |
| Aaron P. Kithcart |
No disclosure on file
|
| Pin-Chia Huang |
No disclosure on file
|
| Maria A. Rocca |
Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. |
| Michael Thomas |
No disclosure on file
|
| Julia Bailey |
No disclosure on file
|
| Amy Kuo |
No disclosure on file
|
| Rajeev Kumar, MD, FRCPC |
The institution of Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevance. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ferrer. Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Research Catalyst, LLC. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for CenExel RMCR. Dr. Kumar has stock in Research Catalyst, LLC. Dr. Kumar has stock in CenExel. Dr. Kumar has stock in Neurofold Therapeutics. The institution of Dr. Kumar has received research support from Supernus. The institution of Dr. Kumar has received research support from Sage Therapeutics. The institution of Dr. Kumar has received research support from Prilenia Therapeutics. The institution of Dr. Kumar has received research support from Roche. The institution of Dr. Kumar has received research support from Triplet Therapeutics. The institution of Dr. Kumar has received research support from CHDI Foundation. The institution of Dr. Kumar has received research support from Neurocrine Biosciences. The institution of Dr. Kumar has received research support from Biovie. The institution of Dr. Kumar has received research support from Neuroderm. The institution of Dr. Kumar has received research support from Sanofi. The institution of Dr. Kumar has received research support from Addex Pharma. The institution of Dr. Kumar has received research support from Integrative Research Laboratories. The institution of Dr. Kumar has received research support from Takeda Pharmaceuticals. The institution of Dr. Kumar has received research support from Neuraly. The institution of Dr. Kumar has received research support from Abbvie. The institution of Dr. Kumar has received research support from Cerevel Therapeutics. The institution of Dr. Kumar has received research support from Transposon Therapeutics. The institution of Dr. Kumar has received research support from Lundbeck. The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Revance Therapeutics. The institution of Dr. Kumar has received research support from Impax Laboratories. The institution of Dr. Kumar has received research support from CND Life Sciences. The institution of Dr. Kumar has received research support from Neuron23. The institution of Dr. Kumar has received research support from Annexon Biosciences. The institution of Dr. Kumar has received research support from Annovis. The institution of Dr. Kumar has received research support from PTC Therapeutics. The institution of Dr. Kumar has received research support from Uniqure. The institution of Dr. Kumar has received research support from Alexza. The institution of Dr. Kumar has received research support from SparkNeuro. The institution of Dr. Kumar has received research support from Praxis. The institution of Dr. Kumar has received research support from Scion Neurostim. The institution of Dr. Kumar has received research support from Cognition Therapeutics. The institution of Dr. Kumar has received research support from Eli Lilly. The institution of Dr. Kumar has received research support from Aribio. The institution of Dr. Kumar has received research support from Biogen. The institution of Dr. Kumar has received research support from Bial R and D investments. The institution of Dr. Kumar has received research support from Ono Pharmaceutical Company. The institution of Dr. Kumar has received research support from UCB Biopharma. The institution of Dr. Kumar has received research support from Vigil Therapeutics. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Medical Director with CenExel RMCR. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as a Managing Member with Research Catalyst, LLC. Dr. Kumar has a non-compensated relationship as a Board Member with Movement Disorders Foundation that is relevant to AAN interests or activities. |
| Charles Anderson |
No disclosure on file
|
| Mohamed Hussein |
No disclosure on file
|
| Damiano Mistri, MSC |
Mr. Mistri has nothing to disclose. |
| Haythum O. Tayeb, MD |
Dr. Tayeb has nothing to disclose. |
| Pawel Drzadzewski |
No disclosure on file
|
| Ralf Reilmann, MD, FAAN |
The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for uniQure. The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WAVE. Dr. Reilmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WAVE. The institution of Dr. Reilmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for IOS-Press. The institution of Dr. Reilmann has received research support from European Union. Dr. Reilmann has a non-compensated relationship as a Executive Committee Member with Huntington Study Group that is relevant to AAN interests or activities. Dr. Reilmann has a non-compensated relationship as a Member of Executive Committee with European Huntington Disease Network that is relevant to AAN interests or activities. Dr. Reilmann has a non-compensated relationship as a Co-Chair Task Force on Huntington Disease with Movement Disorders Socitey that is relevant to AAN interests or activities. |
| Richard George |
No disclosure on file
|
| Sven Forner |
No disclosure on file
|
|
No disclosure on file
|
| Kendra Benisano |
No disclosure on file
|
| Andreas Meier, MD |
Dr. Meier has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Meier has received personal compensation for serving as an employee of Voyager Therapeutics. Dr. Meier has stock in Vigil Neuroscience. Dr. Meier has stock in Voyager Therapeutics. |
| Jongho Lee |
No disclosure on file
|
| Paolo Preziosa |
Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. |
| Omid Mirmosayyeb, MD |
Dr. Mirmosayyeb has nothing to disclose. |
| Roger McIntyre |
Roger McIntyre has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie, Atai Life Sciences. Roger McIntyre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie, Atai Life Sciences. Roger McIntyre has received personal compensation in the range of $5,000-$9,999 for serving as a Research Grant Support with CIHR/GACD/National Natural Science Foundation of China (NSFC) and the Milken Institute. |
| David B. Arciniegas, MD |
Dr. Arciniegas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychiatric Association Publishing. The institution of Dr. Arciniegas has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Arciniegas has received research support from Department of Defense/Congressionally Directed Medical Research Program. The institution of Dr. Arciniegas has received research support from National Institute on Aging. The institution of Dr. Arciniegas has received research support from Department of Health, State of New Mexico. Dr. Arciniegas has received publishing royalties from a publication relating to health care. |
| Rodrigo Mansur |
No disclosure on file
|
| Rajasimhan Rajagovindan, PhD |
Dr. Rajagovindan has received personal compensation for serving as an employee of Biogen. Dr. Rajagovindan has received personal compensation for serving as an employee of Vigil. Dr. Rajagovindan has stock in Biogen. Dr. Rajagovindan has stock in Vigil . |
| Faddi G. Saleh Velez, MD |
Dr. Saleh Velez has nothing to disclose. |
| Alvaro Pascual-Leone, MD, PhD, FAAN |
Dr. Pascual-Leone has received personal compensation for serving as an employee of Linus Health. Dr. Pascual-Leone has received personal compensation for serving as an employee of TI Solutions. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BitBrain. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AscenZion. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroelectrics. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TetraNeuron. Dr. Pascual-Leone has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for TI Solutions. Dr. Pascual-Leone has or had stock in TI Solutions. The institution of Dr. Pascual-Leone has received research support from NIH. The institution of Dr. Pascual-Leone has received research support from NSF. The institution of Dr. Pascual-Leone has received research support from Brightfocus Foundation . Dr. Pascual-Leone has received intellectual property interests from a discovery or technology relating to health care. Dr. Pascual-Leone has received publishing royalties from a publication relating to health care. |
| Joshua Di Vincenzo |
No disclosure on file
|
| Shana Dodge |
Shana Dodge has received personal compensation for serving as an employee of The Association for Frontotemporal Degeneration (AFTD). |
| Jeffrey M. Gelfand, MD, MS, FAAN |
Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities. |
| Kolette Cho |
No disclosure on file
|